Alpima appoints Anastasia Bikou from Goldman Sachs as MD of sales

Alpima, the specialist front-office platform for institutional and professional investors, announces the appointment of Anastasia Bikou as Managing Director of Sales.

  1 Be the first to comment

External

This content is provided by an external author without editing by Finextra. It expresses the views and opinions of the author.

In this newly created role, Anastasia will report to Ilan Heimann, Head of Sales and Partnerships. Anastasia joins Alpima from Goldman Sachs in London where she spent nine years and was most recently responsible for FX distribution to institutional clients across Europe. Before that, Anastasia worked as a Derivatives Trader for the National Bank of Greece and a Financial Analyst at Merrill Lynch in New York. Anastasia holds an MBA in Finance from the Wharton School and Bachelor Degrees in Mechanical Engineering & Business Economics from Brown University.

Commenting on the appointment, Pierre Mendelsohn, Founder and CEO of Alpima said: “We are thrilled to have Anastasia join us. She brings with her a wealth of market experience and a deep knowledge of both the buy and sell-side. She is joining at an exciting time for Alpima as we accelerate our growth. As technology continues to transform investment management, with systematic investing and digital engagement going mainstream, we believe our flexible, client-centric, human plus machine approach will provide a strong point of differentiation.”

Alpima, which counts among its backers Eight Roads, the proprietary investment arm of Fidelity International Limited, is a new generation B2B platform focused on evidence-based investing. Its clients include asset managers, wealth managers, product providers and asset owners.

Sponsored [New Impact Study] Catering to a new generation though unified card programmes

Related Company

Keywords

Comments: (0)

[On-Demand Webinar] Unifying Card Programmes: The cost-reduction imperativeFinextra Promoted[On-Demand Webinar] Unifying Card Programmes: The cost-reduction imperative